FDA Warns Leukemia Drug Could Increase Risk for Rare Blood Pressure Problem

FDA warning

The U.S. Food and Drug Administration recently issued a new drug safety communication, in which the agency reported that the Bristol-Myers Squibb leukemia drug, Sprycel, could potentially increase a patient’s risk for developing a rare high blood pressure problem in the lungs, known as pulmonary arterial hypertension, or PAH. PAH is a condition that causes [...]